Header Logo

Connection

RUI CHEN to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications RUI CHEN has written about Biomarkers, Tumor.
RUI CHEN
Connection Strength
0.017
Biomarkers, Tumor
  1. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. Blood. 2014 Oct 23; 124(17):2705-12.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.